-
1Academic Journal
المؤلفون: Omar Usmani, Grace Li, Jan De Backer, Hosein Sadafi, Libo Wu, Jonathan Marshall
المصدر: Respiratory Research, Vol 24, Iss 1, Pp 1-11 (2023)
مصطلحات موضوعية: Budesonide/glycopyrronium/formoterol fumarate dihydrate (BGF), Chronic obstructive pulmonary disease (COPD), Fluticasone furoate/umeclidinium/vilanterol (FF/UM/VI), In silico functional respiratory imaging (FRI), Lung deposition, Inhaled corticosteroids (ICS), Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1465-993X
-
2Academic Journal
المؤلفون: Sethi S, Clark B, Bengtson LG, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT
المصدر: International Journal of COPD, Vol Volume 18, Pp 625-641 (2023)
مصطلحات موضوعية: copd, tiotropium bromide/olodaterol, fluticasone furoate/umeclidinium/vilanterol, exacerbation history, healthcare resource utilization, cost, clinical outcomes, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Bansal, Sandeep, Anderson, Martin, Anzueto, Antonio, Brown, Nicola, Compton, Chris, Corbridge, Thomas C, Erb, David, Harvey, Catherine, Kaisermann, Morrys C, Kaye, Mitchell, Lipson, David A, Martin, Neil, Zhu, Chang-Qing, Papi, Alberto
المساهمون: Bansal, Sandeep, Anderson, Martin, Anzueto, Antonio, Brown, Nicola, Compton, Chri, Corbridge, Thomas C, Erb, David, Harvey, Catherine, Kaisermann, Morrys C, Kaye, Mitchell, Lipson, David A, Martin, Neil, Zhu, Chang-Qing, Papi, Alberto
مصطلحات موضوعية: Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy, tiotropium monotherapy, COPD
وصف الملف: STAMPA
Relation: info:eu-repo/semantics/altIdentifier/pmid/34035312; info:eu-repo/semantics/altIdentifier/wos/WOS:000658731500001; volume:31; issue:1; firstpage:29-1; lastpage:29-9; numberofpages:9; journal:NPJ PRIMARY CARE RESPIRATORY MEDICINE; http://hdl.handle.net/11392/2457897; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85106921733; https://www.nature.com/articles/s41533-021-00241-z.pdf; https://www.nature.com/articles/s41533-021-00241-z
-
4Academic Journal
المؤلفون: Peter R. Bremner, Ruby Birk, Noushin Brealey, Afisi S. Ismaila, Chang-Qing Zhu, David A. Lipson
المصدر: Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)
مصطلحات موضوعية: COPD, Exacerbations, FEV1, Lung function, Fluticasone furoate/umeclidinium/vilanterol, Randomized controlled trial, Diseases of the respiratory system, RC705-779
وصف الملف: electronic resource
-
5
المؤلفون: Alberto Papi, Mitchell Kaye, Morrys C. Kaisermann, Chang-Qing Zhu, Antonio Anzueto, Catherine Harvey, Sandeep Bansal, David Erb, Neil Martin, David A. Lipson, Chris Compton, Nicola Brown, Thomas C Corbridge, Martin Anderson
المصدر: npj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-9 (2021)
NPJ Primary Care Respiratory Medicineمصطلحات موضوعية: Pulmonary and Respiratory Medicine, Quinuclidines, medicine.medical_specialty, Socio-culturale, Therapeutics, Chlorobenzenes, Placebo, Gastroenterology, Article, Fluticasone propionate, Pulmonary Disease, Chronic Obstructive, tiotropium monotherapy, chemistry.chemical_compound, Diseases of the respiratory system, Medical research, Double-Blind Method, Forced Expiratory Volume, Internal medicine, Administration, Inhalation, medicine, Clinical endpoint, Humans, COPD, In patient, Tiotropium Bromide, Benzyl Alcohols, RC705-779, business.industry, Nebulizers and Vaporizers, Chronic obstructive pulmonary disease, Inhaler, Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy, Public Health, Environmental and Occupational Health, Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy, tiotropium monotherapy, COPD, medicine.disease, Bronchodilator Agents, respiratory tract diseases, Androstadienes, Treatment Outcome, chemistry, UMECLIDINIUM/VILANTEROL, Vilanterol, business, medicine.drug
-
6Academic Journal
المؤلفون: Tabberer, M, Lomas, DA, Birk, R, Brealey, N, Zhu, C-Q, Pascoe, S, Locantore, N, Lipson, DA
المصدر: Advances in Therapy , 35 (1) pp. 56-71. (2018)
مصطلحات موضوعية: Budesonide/formoterol, COPD burden, Fluticasone furoate/umeclidinium/vilanterol, Patient-reported outcomes, Respiratory, Symptom burden
وصف الملف: text
Relation: https://discovery.ucl.ac.uk/id/eprint/10041715/7/Lomas%20VoR%20Tabberer2018_Article_Once-DailyTripleTherapyInPatie.pdf; https://discovery.ucl.ac.uk/id/eprint/10041715/
-
7
المؤلفون: Noushin Brealey, Steve Pascoe, Chang-Qing Zhu, Ruby Birk, Nicholas Locantore, David A. Lomas, David A. Lipson, Maggie Tabberer
المصدر: Advances in Therapy
مصطلحات موضوعية: Budesonide, Male, Quinuclidines, Exacerbation, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Surveys and Questionnaires, Budesonide, Formoterol Fumarate Drug Combination, Pharmacology (medical), 030212 general & internal medicine, Original Research, COPD, Minimal clinically important difference, General Medicine, Middle Aged, Bronchodilator Agents, Respiratory, Symptom burden, Drug Therapy, Combination, Female, Vilanterol, medicine.drug, Adult, medicine.medical_specialty, Chlorobenzenes, Fluticasone propionate, Drug Administration Schedule, COPD burden, 03 medical and health sciences, Double-Blind Method, Internal medicine, Administration, Inhalation, medicine, Humans, Budesonide/formoterol, Benzyl Alcohols, Patient-reported outcomes, business.industry, medicine.disease, Dyspnea, 030228 respiratory system, chemistry, Quality of Life, Fluticasone, Fluticasone furoate/umeclidinium/vilanterol, Formoterol, business
-
8
المؤلفون: Ruby Birk, Chang-Qing Zhu, David A. Lipson, Peter R. Bremner, Noushin Brealey, Afisi S. Ismaila
المصدر: Respiratory Research
Respiratory Research, Vol 19, Iss 1, Pp 1-10 (2018)مصطلحات موضوعية: Budesonide, Male, medicine.medical_specialty, Quinuclidines, Single-inhaler triple therapy, Placebo, Chlorobenzenes, Gastroenterology, Fluticasone propionate, Exacerbations, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, FEV1, 0302 clinical medicine, Double-Blind Method, Internal medicine, Administration, Inhalation, medicine, Humans, COPD, 030212 general & internal medicine, Benzyl Alcohols, Aged, lcsh:RC705-779, business.industry, Inhaler, Nebulizers and Vaporizers, Research, lcsh:Diseases of the respiratory system, Middle Aged, medicine.disease, Fluticasone furoate/vilanterol, Lung function, Bronchodilator Agents, Androstadienes, 030228 respiratory system, chemistry, Randomized controlled trial, Female, Fluticasone furoate/umeclidinium/vilanterol, Vilanterol, Formoterol, business, medicine.drug